1. Kamioka, Hiroshi, Yogosawa, Satomi, Oikawa, Tsunekazu, Saruta, Masayuki, Yoshida, Kiyotsugu. 2023. Dyrk2 gene transfer suppresses hepatocarcinogenesis by promoting the degradation of Myc and Hras. In JHEP reports : innovation in hepatology, 5, 100759. doi:10.1016/j.jhepr.2023.100759. https://pubmed.ncbi.nlm.nih.gov/37333975/
2. Koike, Chihiro, Okudela, Koji, Matsumura, Mai, Tateishi, Yoko, Ohashi, Kenichi. 2020. Frequent DYRK2 gene amplification in micropapillary element of lung adenocarcinoma - an implication in progression in EGFR-mutated lung adenocarcinoma. In Histology and histopathology, 36, 305-315. doi:10.14670/HH-18-294. https://pubmed.ncbi.nlm.nih.gov/33368138/
3. Yoshida, Saishu, Yoshida, Kiyotsugu. 2019. Multiple functions of DYRK2 in cancer and tissue development. In FEBS letters, 593, 2953-2965. doi:10.1002/1873-3468.13601. https://pubmed.ncbi.nlm.nih.gov/31505048/
4. Mao, Cui, Ju, Xing, Cheng, Haijian, Lan, Xianyong, Song, Enliang. 2020. Determination of genetic variation within the DYRK2 gene and its associations with milk traits in cattle. In Archives animal breeding, 63, 315-323. doi:10.5194/aab-63-315-2020. https://pubmed.ncbi.nlm.nih.gov/32964102/
5. Park, Chun Shik, Lacorazza, H Daniel. 2020. DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cells. In Experimental & molecular medicine, 52, 1663-1672. doi:10.1038/s12276-020-00515-5. https://pubmed.ncbi.nlm.nih.gov/33067577/
6. Wu, Chunrong, Sun, Guiyin, Wang, Fan, Quan, Jin, Xiang, Debing. 2022. DYRK2 downregulation in colorectal cancer leads to epithelial-mesenchymal transition induction and chemoresistance. In Scientific reports, 12, 22496. doi:10.1038/s41598-022-25053-0. https://pubmed.ncbi.nlm.nih.gov/36577753/
7. Sun, Yuxiang, Ge, Xin, Li, Mengmeng, Xu, Li, Shen, Yaodong. 2017. Dyrk2 involved in regulating LPS-induced neuronal apoptosis. In International journal of biological macromolecules, 104, 979-986. doi:10.1016/j.ijbiomac.2017.06.087. https://pubmed.ncbi.nlm.nih.gov/28676338/
8. Salahudeen, Ameen A, Seoane, Jose A, Yuki, Kanako, Curtis, Christina, Kuo, Calvin J. 2023. Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesis. In Cell reports, 42, 113355. doi:10.1016/j.celrep.2023.113355. https://pubmed.ncbi.nlm.nih.gov/37922313/
9. Wang, Yuchan, Wu, Yaxun, Miao, Xiaobing, Xu, Xiaohong, He, Song. 2015. Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma. In International journal of biological macromolecules, 81, 809-17. doi:10.1016/j.ijbiomac.2015.08.067. https://pubmed.ncbi.nlm.nih.gov/26341817/
10. Yokoyama-Mashima, Shiho, Yogosawa, Satomi, Kanegae, Yumi, Oikawa, Tsunekazu, Yoshida, Kiyotsugu. 2019. Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer. In Cancer letters, 451, 100-109. doi:10.1016/j.canlet.2019.02.046. https://pubmed.ncbi.nlm.nih.gov/30851422/
智鼠故事 
